Cardio Diagnostics Holdings, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent
Cardio Diagnostics Holdings, Inc. (CDIO) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent of 0.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization · last filed 2025-03-20
- Cardio Diagnostics Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2024 was 0.00%, a 100.00% decline from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2023 was 16.80%.
- Cardio Diagnostics Holdings, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent 12 month |
|---|---|
| 2024-12-31 | 0.00% 10-K · filed 2025-03-20 |
| 2023-12-31 | 16.80% 10-K · filed 2025-03-20 |
| 2022-12-31 | 0.00% 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |